A series of patients with hyperuricaemia associated with rheumatic symptoms were treated with Benzbromarone (Minuric®) and followed over a period of 5 months. Each patient was assessed clinically and biochemically before and at regular monthly intervals during the trial.
All patients showed a marked reduction in serum uric acid levels and a significant increase in urinary uric acid elimination rates. Some degree of clinical improvement was noted in most patients and the drug was well tolerated throughout the study. Two patients were withdrawn during the trial; one because of diarrhoea, probably due to benzbromarone and the other because of lack of efficacy.
CharbonnetFRossierJ C (1973) Benzbromarone in the treatment of hyperuricaemia. Praxis62 (44), 1337.
3.
DelbarreF (1966) Encyclopédic Medico-Chirugicale. Paris
4.
Delbarre (1973) Treatment of gout with a bromine derivative of benzofuran. Rev. Rhum. and Mal. Ostéoartic. 40, 273.
5.
DixonA St J (1965) Progress in Clinical Rheumatology. 1st Ed.Churchill, London. p. 268.
6.
Greibsch vonAZollnerN (1973) Normal values of plasma uric acid in South Germany. Comparisons with determinations made ten years ago. Z. Klin. Chem. Klin. Biochem. 11, Jg. S 346.
7.
HoffmanW W (1968) The other face of gout. Medical Times96, 8, 787.
8.
MasbernardAFrancozP (1969) The uricosuric action of benzbromarone. Therapiewoche19, 1553.
9.
MertzD P (1969) Alterations in blood uric acid levels with benzbromarone. Münch. Med. Wschr. 111 (9), 491.
10.
ShermanM S (1946) Archives of Pathology42, 557.
11.
TalbottJ H (1967) Gout.3rd Ed.Grune and Stratton, New York. p. 92.
12.
WattsB W F (1971) Quarterly Journal of MedicineXL, 157.
13.
ZöllnerN (1968) Reduction in serum uric acid levels using benzbromarone. Klinische Wochenschrift46, 1318.
